BeStock  
Markets › Compare › BNTX vs ALNY

BNTX vs ALNY

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
BNTX · BioNTech$97.26 ▼ 1.06%
ALNY · Alnylam Pharmaceuticals$236.56 ▼ 4.13%

Head to head

MetricBNTXALNY
Price$97.26$236.56
Change today▼ 1.06%▼ 4.13%
Market cap$24.43B$31.65B
Return, 3 months+3.6%–
Return, year to date+2.2%–
Return, 1 year-4.8%–
P/E (TTM)-12.841.2
P/B1.223.4
P/E percentile vs own 5y41st84th
Dividend yield––
Revenue growth (YoY, latest qtr)-59.5%+66.9%
Net profit growth (YoY)-112.3%+327.7%
Gross margin75.5%79.7%
Operating margin-46.4%20.8%
Net margin-63.6%16.1%
Return on equity-9.3%96.6%
Analyst target vs. price+30.4%+56.4%
Analyst buy share79%86%
RSI (14)48–
30-day volatility71.8%–
Max drawdown, 1 year-29.7%–
Trend readStrong downtrend–
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • ALNY is the largest of the group by market value.
  • BNTX carries the lowest trailing P/E.
  • ALNY is growing revenue fastest.
  • ALNY keeps the most profit per dollar of sales.

Go deeper

Scroll to Top